Xencor
$35.389876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$35.38
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.10 (-0.28%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell Xencor and other stocks, options, ETFs, and crypto commission-free!
About XNCR
Xencor, Inc. engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions. Read More The company was founded by Bassil I. Dahiyat and Stephen L. Mayo in August 1997 and is headquartered in Monrovia, CA.
Employees
156
Headquarters
Monrovia, California
Founded
1997
Market Cap
2.00B
Price-Earnings Ratio
42.83
Dividend Yield
0.00
Average Volume
351.35K
High Today
$36.44
Low Today
$35.10
Open Price
$35.69
Volume
254.64K
52 Week High
$47.60
52 Week Low
$27.75
Collections
Price Paid on Robinhood
9% Higher
Right Now
52 Week Low
$27.57
Average Price Paid
$32.31
52 Week High
$48.38
Analyst Ratings
73%
of 11 ratings
Buy
73%
Hold
18%
Sell
9%
XNCR Earnings
-$0.62
$0.05
$0.71
$1.38
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
Expected Nov 4, After Hours